Alpine Woods Capital Investors, LLC Abbott Laboratories Transaction History

Alpine Woods Capital Investors, LLC

$626 Million
Q3 2024

A detailed history of Alpine Woods Capital Investors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Alpine Woods Capital Investors, LLC holds 4,011 shares of ABT stock, worth $473,137. This represents 0.07% of its overall portfolio holdings.

Number of Shares

4,011

Previous 4,011 -0.0%

Holding current value

$473,137

Previous $416,000 9.86%

% of portfolio

0.07%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$95.53 - $114.62 $116,546 - $139,836	-1,220 Reduced 23.32%	4,011 $388,000
Q2 2023 Aug 02, 2023	SELL	$100.78 - $112.29 $1.04 Million - $1.16 Million	-10,348 Reduced 66.42%	5,231 $570,000
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $400,031 - $470,861	-4,130 Reduced 20.95%	15,579 $1.58 Million
Q4 2022 Feb 08, 2023	SELL	$95.06 - $111.52 $36,122 - $42,377	-380 Reduced 1.89%	19,709 $2.16 Million
Q3 2022 Oct 31, 2022	BUY	$96.76 - $112.03 $251,576 - $291,278	2,600 Added 14.87%	20,089 $1.94 Million
Q2 2022 Aug 02, 2022	SELL	$102.07 - $123.37 $17,351 - $20,972	-170 Reduced 0.96%	17,489 $1.9 Million
Q1 2022 May 10, 2022	SELL	$114.02 - $139.04 $30,443 - $37,123	-267 Reduced 1.49%	17,659 $2.09 Million
Q4 2021 Feb 03, 2022	SELL	$115.53 - $141.46 $544,377 - $666,559	-4,712 Reduced 20.81%	17,926 $2.52 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $571,634 - $632,394	-4,900 Reduced 17.79%	22,638 $2.67 Million
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $969,353 - $1.14 Million	-9,163 Reduced 24.97%	27,538 $3.19 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $67,480 - $79,502	-620 Reduced 1.66%	36,701 $4.4 Million
Q4 2020 Feb 01, 2021	BUY	$105.0 - $114.42 $231,630 - $252,410	2,206 Added 6.28%	37,321 $4.09 Million
Q3 2020 Nov 02, 2020	BUY	$91.64 - $111.29 $344,932 - $418,895	3,764 Added 12.01%	35,115 $3.82 Million
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $36,753 - $47,040	-480 Reduced 1.51%	31,351 $2.87 Million
Q1 2020 May 04, 2020	BUY	$62.82 - $91.86 $263,529 - $385,352	4,195 Added 15.18%	31,831 $2.51 Million
Q4 2019 Feb 07, 2020	BUY	$78.51 - $87.4 $706,590 - $786,600	9,000 Added 48.29%	27,636 $2.4 Million
Q2 2019 Aug 05, 2019	SELL	$72.88 - $85.0 $7,288 - $8,500	-100 Reduced 0.53%	18,636 $1.57 Million
Q1 2019 May 06, 2019	BUY	$66.22 - $80.06 $152,637 - $184,538	2,305 Added 14.03%	18,736 $1.5 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $32,648 - $36,986	498 Added 3.13%	16,431 $1.19 Million
Q3 2018 Nov 08, 2018	BUY	$60.81 - $73.36 $200,673 - $242,088	3,300 Added 26.12%	15,933 $1.17 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $607,141 - $677,634	12,633	12,633 $674,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.

Account

Alpine Woods Capital Investors, LLC Abbott Laboratories Transaction History